Olfr46 Inhibitors
Olfr46, a key member of the olfactory receptor family, plays a pivotal role in initiating neuronal responses to odorant molecules, culminating in the perception of smell. As a G-protein-coupled receptor (GPCR), Olfr46 shares structural characteristics with neurotransmitter and hormone receptors, serving as a crucial mediator in the intricate process of odorant signal transduction. The olfactory receptor gene family, with Olfr46 as a prominent member, stands as the largest in the genome, underscoring its significance in olfactory perception. Inhibition of Olfr46 involves a diverse range of chemical interventions that target various GPCR-associated pathways. Cisplatin induces DNA damage, impacting cellular processes associated with olfactory signal transduction and indirectly inhibiting Olfr46. Wortmannin inhibits PI3-kinase, disrupting PI3-kinase-dependent processes involved in GPCR-mediated signal transduction. 2-APB influences calcium signaling by inhibiting IP3 receptors, potentially impacting Olfr46 function through calcium-dependent processes.
Additionally, NF-κB inhibitor modulates NF-κB signaling, affecting GPCR-related pathways, while Propranolol, a beta-adrenergic receptor antagonist, modifies GPCR-related pathways. BAPTA-AM, a calcium chelator, alters calcium-dependent processes, indirectly influencing Olfr46 function. These inhibitors offer valuable insights into potential interventions for Olfr46, providing a nuanced understanding of the intricate mechanisms involved in olfactory signal transduction at the molecular level.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
DNA cross-linking agent impacting cellular processes involved in olfactory signal transduction. Indirectly inhibits Olfr46 by inducing DNA damage and downstream effects on gene expression associated with GPCR signaling pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3-kinase inhibitor altering intracellular signaling pathways. Indirectly influences olfactory receptor function by disrupting PI3-kinase-dependent processes involved in GPCR-mediated signal transduction. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
IP3 receptor inhibitor affecting calcium signaling. Disrupts GPCR-related pathways by modulating intracellular calcium levels, potentially impacting Olfr46 function through calcium-dependent processes in olfactory signal transduction. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor disrupting MAPK pathway. Influences GPCR-mediated signal transduction, potentially inhibiting Olfr46 function through the downstream modulation of MAPK signaling. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Modulator of NF-κB signaling impacting GPCR-related pathways. Alters intracellular processes, potentially inhibiting Olfr46 function through the disruption of NF-κB-mediated cascades involved in olfactory signal transduction. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Beta-adrenergic receptor antagonist impacting GPCR signaling. Modifies intracellular pathways involved in olfactory signal transduction, potentially inhibiting Olfr46 function through modulation of beta-adrenergic receptor-mediated processes. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Intracellular calcium chelator affecting GPCR-mediated signal transduction. Alters calcium-dependent processes, indirectly influencing Olfr46 function by modulating downstream signaling cascades. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAP kinase inhibitor impacting MAPK signaling pathways. Modulates cellular responses downstream of GPCR activation, potentially inhibiting Olfr46 function through the MAPK cascade. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3-kinase inhibitor impacting GPCR-related signaling pathways. Modulates intracellular processes, indirectly influencing Olfr46 function through the disruption of PI3-kinase-dependent cascades. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
PKC inhibitor targeting downstream GPCR signaling. Modifies intracellular pathways involved in olfactory signal transduction, potentially inhibiting Olfr46 function through PKC-mediated processes. | ||||||